Nalidixic acid (Negram), a naphthyridine derivative, is a new chemotherapeutic agent, which is highly active in vitro against a wide range of Gramnegative organisms and has been reported to be particularly effective in vivo in urinary tract infections (Barlow, 1963; Lishman and Swinney, 1963; WardMcQuaid, Jichlinski, and Macis, 1963) . Although in laboratory tests the gonococcus was found to be very sensitive to nalidixic acid, early clinical trials with doses usually recommended for urinary tract infections had been disappointingt. The only positive results were reported from Mexico by Aparicio (1962) , who treated thirty cases of gonorrhoea, 23 in the male and 7 in the female, with 1 g. four times a day over 5 to 8 days and attained apparent cure in 24. However, he followed up the patients for not more than a week and the majority for less than 5 In both cases the gonococcus was sensitive in vitro to nalidixic acid and penicillin disks, both before treatment and after its failure. There were no sideeffects. The patients were successfully re-treated with 600,000 units procaine penicillin fortified by 200,000 units potassium benzyl-penicillin.
Blood samples for spectrophotofluorometric assay of nalidixic acid plasma levels were collected from the patients immediately before and 1, 2, 4, 6, and 8 hours after the drug was taken (Fig. 1, opposite) . In one the peak was higher and the rise and decline steeper than in the other, but in both cases the level after 6 hours was still above 25 ,tg. per ml.
These preliminary investigations confirmed that nalidixic acid was active against the gonococcus both in vitro and in vivo, and that after a single dose of 4 g. a high plasma level was attained within 1 Although all the patients, except those who have defaulted, are still kept under review, for the purpose of this report the tests for cure were performed 3 weeks after treatment, when the fluid expressed by prostatic massage was examined by smear and culture. Before that the patients were examined at least twice during the first week and the majority also twice during the second week.
As a rule cases which failed to respond to nalidixic acid were treated with penicillin, but seven patients were treated twice with nalidixic acid, viz. five after failure of penicillin, all again without success, and two after re-infection, both successfully. This gives a total of 83 treatments performed at nine different dosage schedules.
Results
The results in relation to dosage are shown in Table II . The group treated with a single dose includes the two preliminary patients and two more who vomited after the first dose and discontinued treatment. In the following five groups, treatment consisted of an initial dose of 4 g. and from one to five further doses of 2 g. at 6-hrly intervals. In general the success rate increased with the number of doses given; in the group of nineteen patients treated with 14 g. over 30 hrs, there were only three definite failures. The highest failure rate, excluding the single dose group, was in the group of eight patients who, after a loading dose of4 g., received from two to six subsequent doses of less than 2 g. (1 or 1 -5 g.); here there were six failures in the seven patients who were followed up. Of the three patients who were treated with five equal doses of 2 g. over 24 hrs, one was cured and two failed, and of the four who were treated with an initial dose of 3 g. and three doses of 2 g. over 12 hrs two were cured and two failed.
All the re-infections occurred within the first fortnight and sexual re-exposure was admitted by the patients. Of the defaulters*, five ceased to attend within 10 days of the completion of treatment, one received some tablets (presumably sulphonamides) from his own doctor during the follow-up period, and one was found to have syphilis for which treatment was started at the clinic; the last case is later described in detail.
* Since the report was read two of the defaulters re-appeared at the clinic with a re-infection: one 4 weeks after treatment with 12 g. over 24 hrs, the other 6 weeks after treatment with 14 g. over 30 hrs.
Treatment failures (Table III) all became apparent within the first week. In three cases, of which two were treated with 12 g. over 24 hrs and one with 14 g. over 30 hrs, the gonococcus was resistant to nalidixic acid in vitro; in two of them the urethral discharge remained purulent from the first and the gonococcus was found in smears and cultures after 24 hrs; in the third case the gonococcus was sensitive before treatment and resistant after the relapse which occurred on the third day.
Penicillin Resistant Cases (Table IV) Patients Sensitized to Penicillin.-Two patients who were known to be sensitized to penicillin were successfully treated with nalidixic acid, 12 g. over 24 hrs and 14 g. over 30 hrs respectively. Plasma Levels (Fig. 2 ).-Plasma levels of the drug were estimated by spectrophotofluorometric assay at various times during and after treatment in the ten patients admitted to hospital and single estimations were made in nine of the patients treated at the clinic. Blood samples from the latter were collected between 20 and 24 hrs and in two cases 30 hrs after (Table V) .-There were two cases of primary syphilis (briefly described later), nine of non-gonorrhoeal urethritis of which three were due to trichomonas infection, six of asymptomatic non-specific prostatitis which were detected on routine examination for cure of gonorrhoea 3 weeks after treatment, and four cases of scabies. Positive serological tests for syphilis were detected in two West Indians who had suffered from yaws in childhood and the gonococcal complement-fixation test was positive in a Pakistani with a history of two previous gonorrhoeal infections. Of the two patients with primary syphilis one, a Pakistani aged 29, already had an ulcer on the glans penis when he was first examined and was found to be suffering from acute gonorrhoea. The ulcer was secondarily infected with pyogenic organisms and had been treated with an antiseptic ointment and the search for Treponemna pallidunm was unavailing. He was treated with nalidixic acid (4 g. initially and two doses of 2 g.) and when he attended after 48 hours numerous Treponenma pallida were detected in a clear exudate from the ulcer. Penicillin treatment was started and for convenience this patient was included in the group of defaulters. The serological tests in this case were positive.
The second patient, an unmarried Englishman aged 30 years, attended the clinic with gonorrhoea 11 days after sexual exposure. He was treated with 12 g. of nalidixic acid over 24 hrs and was seen on the 2nd, 3rd, and 7th day after treatment. There was no urethral discharge from the 3rd day onwards. When he attended on the 10th day a papule about 8 mm. in diameter with a slightly eroded surface and well defined outlines was noted on the inner aspect of the prepuce and Treponema pallidum was demonstrated in the serum from the lesion. Before treatment with penicillin was started prostatic smears and cultures were taken; as they were negative, this patient was included in the group of nalidixic acid successes. The serological tests in this case were negative.
Side-efjects (Table VI) .-These occurred in twenty patients, but were not severe and did not prevent the patients from working. The most frequent complaint was dizziness which in seven cases was associated either with headache or with nausea. One patient had transient diplopia after each dose of the drug. The four patients who vomited were all Pakistanis working at night and all of them, it was later discovered, had received the first dose on an empty stomach. All of them were treatment failures. There were no side-effects in any of the patients who were treated in hospital. Obviously nalidixic acid has all the disadvantages of any drug requiring multiple doses by mouth and cannot be recommended for the routine treatment of gonorrhoea. The fact, demonstrated by two cases in this series, that it has no effect whatever upon Treponema pallidum makes it a probable drug of choice in cases of gonorrhoea in which a concomitant early syphilis is suspected. It may also be useful for treatment of gonorrhoea in patients sensitized to penicillin. Summary 76 male patients with acute uncomplicated urethral gonorrhoea were treated with nalidixic acid using nine different dosage schedules.
In general the success rate increased with the increase in dosage and a significant proportion of cures was attained with an initial dose of 4 g. and five further doses of 2 g. given at 6-hrly intervals.
Plasma levels of the drug were assayed in nineteen patients and the results suggest that 25 Fg./ml. is probably the lowest effective level.
In two cases of concomitant primary syphilis, nalidixic acid showed no effect upon Treponema pallidum.
The unusually large doses of the drug which were used in this trial were well tolerated and the sideeffects (which occurred in twenty patients) were on the whole not severe.
It is concluded that nalidixic acid cannot be recommended for routine treatment of gonorrhoea, but that it may be useful in cases in which concomitant early syphilis is suspected and in cases of sensitization to penicillin.
